What happens when athletes stop training for 10 days? Dr. Lazzara discusses a study of resting cerebral blood flow in gray matter and the hippocampus.
ANA 2016: Risk Factors with Neurological Disorders
Award-winning posters presented during the American Neurological Association Annual Meeting discussed risks in stroke, MS, and migraine.
Do Brain-Training Exercises Work?
Dr. Bobby Lazzara discusses a study examining the validity of close to 400 research papers supporting the effectiveness of brain-training programs.
Patient H.M. & Neurology Research: Ethical or Not?
Although tremendous advances in research and medical ethics have been made since the mid-20th century, questions continue.
Ischemic Stroke & Thrombectomy: Time to Treat
What is the ideal time frame in which to perform endovascular thrombectomy after large-vessel ischemic stroke?
Interesting Neuro: Stroke Therapy & Zika Updates
Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.
The Brain and Nostalgia
Nostalgic experiences trigger metabolic activity and blood flow in several brain regions and can be a useful emotional strategy or a harmful addiction.
Promising Alzheimer Antibody-Based Immunotherapy
Dr. Bobby Lazzara reports on a clinical trial of aducanumab, a human monoclonal antibody, in patients with prodromal or mild Alzheimer disease.
Exercise and Cerebral Blood Flow
Neuro News Roundup: Potential MS Therapies
Three new multiple sclerosis studies show the promise of two drugs, amiselimod and alemtuzumab, as treatments and one, arbaclofen, for spasticity.
Interesting Neuro: ECTRIMS News & Alzheimer Marker
Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.
By clicking Accept, you agree to become a member of the UBM Medica Community.